Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human monoclonal antibody against activin receptor type IIB

EU orphan designation number: EU/3/12/1035   
Active ingredient: Recombinant human monoclonal antibody against activin receptor type IIB
Indication: Treatment of inclusion body myositis
Sponsor: Novartis Europharm Limited
Frimley Business Park, Camberley GU16 7SR, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/08/2012 Orphan Designation EMA/OD/046/12 (2012)5799 of 09/08/2012
29/08/2014 Change of address of sponsor